Girl with leukemia in remission after gene treatment

12/10/2012 | New York Times (tiered subscription model), The

A girl with acute lymphoblastic leukemia experienced remission after being treated with an experimental therapy that used a disabled form of HIV to genetically reprogram her immune system to fight the cancer. The girl is the first child to undergo the treatment, and some experts said it could someday serve in place of bone marrow transplants. Novartis has expressed interest in the treatment and has pledged $20 million to establish a research center for it at the University of Pennsylvania.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA